US Stock MarketDetailed Quotes

OGEN Oragenics

Watchlist
  • 1.0700
  • +0.0199+1.90%
Close May 3 16:00 ET
4.79MMarket Cap-116P/E (TTM)

About Oragenics Company

Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.

Company Profile

SymbolOGEN
Company NameOragenics
Listing DateJul 3, 2003
Founded1996
CEOMr. Joseph Michael Redmond
MarketAMEX
Employees5
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4902 Eisenhower boulevard,Suite 125
CityTampa
ProvinceFlorida
CountryUnited States of America
Zip Code33634-6310
Phone1-813-286-7900
Websitehttp://www.oragenics.com

Company Executives

  • Name
  • Position
  • Salary
  • Janet Huffman
  • Chief Financial Officer, Secretary,Treasurer and Principal Accounting Officer
  • --
  • Joseph Michael Redmond
  • President and Interim Principal Executive Officer
  • --
  • Charles L. Pope
  • Interim Executive Chairman of the Board
  • 159.51K
  • Kimberly M. Murphy
  • Director
  • 37.94K
  • Bruce A. Cassidy,Sr
  • Independent Director
  • --
  • Robert C. Koski
  • Independent Director
  • 132.01K
  • John P. Gandolfo
  • Independent Director
  • --
  • Dr. Frederick W. Telling,PhD
  • Independent Director
  • 299.70K
  • Dr. Alan W. Dunton,M.D.
  • Independent Director
  • 152.84K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg